Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29077037 | 0.95 | TP53 (0.39) | TP53SMN1; SMN2LMNAALDH1A1KDM4E | |
| SCHEMBL28362759 | 0.80 | RECQL (0.32) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL6663669 | 0.78 | LMNA (0.40) | TP53SMN1; SMN2LMNAALDH1A1KDM4E | |
| Dodecanoate SCHEMBL6416181 | 0.78 | MEN1 (0.52) | LMNAALDH1A1TSHRKDM4EDUSP3 | |
| Dodecanoate SCHEMBL6416174 | 0.78 | KDM4E (0.52) | LMNARECQLGLAHPGDTSHR | |
| SCHEMBL27785265 | 0.76 | LMNA (0.38) | TP53SMN1; SMN2LMNAALDH1A1KDM4E | |
| SCHEMBL10585264 | 0.76 | LMNA (0.38) | TP53SMN1; SMN2LMNAALDH1A1KDM4E | |
| SCHEMBL276968 | 0.76 | LMNA (0.38) | TP53SMN1; SMN2LMNAALDH1A1KDM4E | |
| SCHEMBL8974799 | 0.76 | SLC22A16 (0.43) | SMN1; SMN2LMNARECQLGLAHPGD | |
| Glycerin SCHEMBL1712543 | 0.75 | TP53 (0.58) | TP53SMN1; SMN2LMNAALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109999120-A | Remove heel cracking bubble foot piece and preparation method thereof | 杭州康韵语医疗科技有限公司 | 2019-07-12 | — | — | CN | claimed |
| EP-0557423-B1 | MILD SKIN CLEANSING TOILET BAR WITH SILICONE SKIN MILDNESS/MOISTURIZING AID | PROCTER & GAMBLE (US) | 1996-08-14 | — | — | EP | claimed |
| CN-1029856-C | Mild skin cleansing toilet bar with silicone skin mildness/moisturizing aid | PROCTER & GAMBLE (US) | 1995-09-27 | — | — | CN | claimed |
| EP-0557423-A1 | MILD SKIN CLEANSING TOILET BAR WITH SILICONE SKIN MILDNESS/MOISTURIZING AID. | PROCTER & GAMBLE (US) | 1993-09-01 | — | — | EP | claimed |
| US-5154849-A | MILD SKIN CLEANSING TOILET BAR WITH SILICONE SKIN MILDNESS/MOISTURIZING AID | THE PROCTER & GAMBLE COMPANY (US) | 1992-10-13 | — | — | US | claimed |
| CN-1062373-A | The clean skin perfumed soap of mild that contains siloxanes skin gentleness/moisturizing aid | PROCTER & GAMBLE (US) | 1992-07-01 | — | — | CN | claimed |
| WO-1992008444-A1 | MILD SKIN CLEANSING TOILET BAR WITH SILICONE SKIN MILDNESS/MOISTURIZING AID | THE PROCTER & GAMBLE COMPANY (US) | 1992-05-29 | — | — | WO | claimed |
| US-20260098007-A1 | Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light | SOLIOME INC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4648740-A1 | USE OF UNSATURATED FATTY ACID AMIDOPROPYL BETAINES AS THICKENERS | BASF SE (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4587007-A2 | COMPOUNDS AND THEIR USE IN FILTERING ULTRAVIOLET AND/OR HIGH-ENERGY VISIBLE LIGHT | Soliome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| EP-4587635-A2 | FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS | Evolved by Nature, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250230203-A1 | FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS | EVOLVED BY NATURE, INC. | 2025-07-17 | — | — | US | disclosed |
| WO-2024059862-A9 | FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS | EVOLVED BY NATURE, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| EP-0313305-A2 | Photoprotection compositions comprising chelating agents | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-26 | — | — | EP | disclosed |
| EP-0313302-A2 | Photoprotection compositions comprising sorbohydroxamic acid | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-26 | — | — | EP | disclosed |
| EP-0313303-A2 | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-26 | — | — | EP | disclosed |
| EP-0313304-A2 | Photoprotection compositions comprising tocopherol sorbate | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-26 | — | — | EP | disclosed |
| CN-87107801-A | Sulfonyl peroxycarboxylic acids | — | 1988-05-18 | — | — | CN | disclosed |
| US-4179392-A | CONNECTS TO SUCTION LINE OF A HYDRAULIC SYSTEM/ TIVE ATOM IN A POSITION 2 TO 5 FROM THE CARBOXYL ATOM | MOBIL OIL CORPORATION (US) | 1979-12-18 | — | — | US | disclosed |
| US-3969399-A | CALCIUM 1-HYDROXY-3-(SODIUM SULFONATO)-BUTANESULFONATE | M & T CHEMICALS INC. (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098007-A1 | Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light | UGT8, UGT1A3, FUT5 | TP53 2271/4885SMN1; SMN2 3385/4885LMNA 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.